Literature DB >> 22988559

Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery.

Laura M Ensign1, Craig Schneider, Jung Soo Suk, Richard Cone, Justin Hanes.   

Abstract

A method that could provide more uniform and longer-lasting drug and gene delivery to mucosal surfaces holds the potential to greatly improve the effectiveness of prophylactic and therapeutic approaches for numerous diseases and conditions, including sexually transmitted infections, cystic fibrosis, chronic rhinosinusitis, inflammatory bowel disease, and glaucoma to name a few. However, the body's natural defenses, including adhesive, rapidly cleared mucus linings coating nearly all entry points to the body not covered by skin, has limited the effectiveness of drug and gene delivery by nanoscale delivery systems. This article discusses the recent development of the “mucuspenetrating particle” or “MPP” nanotechnology, and how it has been used to both enhance understanding of the nanoscale barrier properties of human mucus secretions, and to achieve more uniform and longer-lasting drug delivery to mucosal tissues following topical administration. Drug loaded MPPs possess non-adhesive coatings that allow them to rapidly penetrate mucus layers through openings in the mucus mesh at rates nearly as fast as they would penetrate pure water. Critically, MPPs allow enhanced drug and gene delivery to mucosal tissues without diminishing the protective function of mucus. Recent progress in the development of MPPs as a biophysical tool to probe the length-scale dependent rheological properties of mucosal secretions and as a method for drug and gene delivery is highlighted.

Entities:  

Mesh:

Year:  2012        PMID: 22988559      PMCID: PMC3710133          DOI: 10.1002/adma.201201800

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  50 in total

Review 1.  Barrier properties of mucus.

Authors:  Richard A Cone
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

2.  Human cervical mucus and its interaction with sperm: a fine-structural view.

Authors:  A I Yudin; F W Hanson; D F Katz
Journal:  Biol Reprod       Date:  1989-03       Impact factor: 4.285

3.  Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery.

Authors:  K Nakamura; Y Maitani; A M Lowman; K Takayama; N A Peppas; T Nagai
Journal:  J Control Release       Date:  1999-09-20       Impact factor: 9.776

4.  Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.

Authors:  Jung Soo Suk; Samuel K Lai; Nicholas J Boylan; Michelle R Dawson; Michael P Boyle; Justin Hanes
Journal:  Nanomedicine (Lond)       Date:  2011-02       Impact factor: 5.307

Review 5.  Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces.

Authors:  Y Huang; W Leobandung; A Foss; N A Peppas
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

6.  Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus.

Authors:  N N Sanders; S C De Smedt; S H Cheng; J Demeester
Journal:  Gene Ther       Date:  2002-03       Impact factor: 5.250

7.  Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.

Authors:  Assem-Galal Ziady; Christopher R Gedeon; Timothy Miller; William Quan; Jennifer M Payne; Susannah L Hyatt; Tamara L Fink; Osman Muhammad; Sharon Oette; Tomasz Kowalczyk; Murali K Pasumarthy; Robert C Moen; Mark J Cooper; Pamela B Davis
Journal:  Mol Ther       Date:  2003-12       Impact factor: 11.454

8.  Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.

Authors:  Samuel K Lai; Kaoru Hida; Shetha Shukair; Ying-Ying Wang; Anna Figueiredo; Richard Cone; Thomas J Hope; Justin Hanes
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

9.  Long-term transgene expression in the central nervous system using DNA nanoparticles.

Authors:  David M Yurek; Anita M Fletcher; George M Smith; Kim B Seroogy; Assem G Ziady; Joseph Molter; Tomasz H Kowalczyk; Linas Padegimas; Mark J Cooper
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

10.  Altering mucus rheology to "solidify" human mucus at the nanoscale.

Authors:  Samuel K Lai; Ying-Ying Wang; Richard Cone; Denis Wirtz; Justin Hanes
Journal:  PLoS One       Date:  2009-01-28       Impact factor: 3.240

View more
  47 in total

1.  Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties.

Authors:  Alex Rygg; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2015-12-21       Impact factor: 4.200

2.  Nanoparticles in the ocular drug delivery.

Authors:  Hong-Yan Zhou; Ji-Long Hao; Shuang Wang; Yu Zheng; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

3.  Enema ion compositions for enhancing colorectal drug delivery.

Authors:  Katharina Maisel; Sumon Chattopadhyay; Thomas Moench; Craig Hendrix; Richard Cone; Laura M Ensign; Justin Hanes
Journal:  J Control Release       Date:  2015-04-30       Impact factor: 9.776

4.  Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery.

Authors:  Guihong Chai; Amr Hassan; Tuo Meng; Lihua Lou; Jonathan Ma; Russell Simmers; Lei Zhou; Bruce K Rubin; Qi Tony Zhou; P Worth Longest; Michael Hindle; Qingguo Xu
Journal:  Nanomedicine       Date:  2020-07-03       Impact factor: 5.307

5.  Pharmaceutical nanoparticles and the mucin biopolymer barrier.

Authors:  Ghaith Aljayyoussi; Muthanna Abdulkarim; Peter Griffiths; Mark Gumbleton
Journal:  Bioimpacts       Date:  2012-11-22

Review 6.  Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Authors:  Darren Michael Moss; Marco Siccardi
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 7.  Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.

Authors:  Ali Keshavarz; Hossam Kadry; Ahmed Alobaida; Fakhrul Ahsan
Journal:  Expert Opin Drug Deliv       Date:  2020-02-19       Impact factor: 6.648

Review 8.  The Mucus Barrier to Inhaled Gene Therapy.

Authors:  Gregg A Duncan; James Jung; Justin Hanes; Jung Soo Suk
Journal:  Mol Ther       Date:  2016-09-20       Impact factor: 11.454

9.  Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery.

Authors:  Jasmim Leal; Xiujuan Peng; Xinquan Liu; Dhivya Arasappan; Dennis C Wylie; Sarah H Schwartz; Jason J Fullmer; Bennie C McWilliams; Hugh D C Smyth; Debadyuti Ghosh
Journal:  J Control Release       Date:  2020-03-31       Impact factor: 9.776

10.  Hydrophobic-core PEGylated graft copolymer-stabilized nanoparticles composed of insoluble non-nucleoside reverse transcriptase inhibitors exhibit strong anti-HIV activity.

Authors:  Anita Leporati; Mikhail S Novikov; Vladimir T Valuev-Elliston; Sergey P Korolev; Anastasia L Khandazhinskaya; Sergey N Kochetkov; Suresh Gupta; Julian Goding; Elijah Bolotin; Marina B Gottikh; Alexei A Bogdanov
Journal:  Nanomedicine       Date:  2016-07-25       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.